Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Antiviral Won't Improve Bell's Palsy Outcome

Cheap, standard treatment best against the facial paralysis, study finds

By Randy Dotinga
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Bell's Palsy
Brain and Spinal Cord Magnetic Resonance Imaging
Brain Tumors
More...

Related Healthscout Videos
 border=
New Drugs That Could Stop MS
New Therapy for Stroke Patients
Mapping the Brain     
Hope for MS
More...

Related Drug Information
 border=
Adderal XR
Concerta
Coumadin
Depakote
More...

Related News Articles
 border=
Health Tip: Signs That a Child May Be Autistic
Exercise Keeps the Brain Young
FDA Approves New Drug for Severe Epilepsy
Marijuana-like Drug Fights Alzheimers
More...

WEDNESDAY, Oct. 17 (HealthDay News) -- The antiviral drug acyclovir is no better at easing a form of facial paralysis called Bell's palsy than traditional treatment, a new study finds.

The fact that acyclovir may not be a new, improved treatment option comes as bad news for patients, experts say, but on the other hand, many people afflicted with Bell's palsy do get better with the current regimen.

Text Continues Below



The study results suggest that these patients may not need to spend money on a second drug that's hardly cheap, noted Dr. Donald Gilden, chairman of the University of Colorado's department of neurology, in Denver.

The study "will likely change practice" by convincing doctors to avoid acyclovir when treating Bell's palsy, said Gilden, who co-authored a commentary accompanying the study findings, published in the Oct. 18 issue of the New England Journal of Medicine.

Bell's palsy strikes up to 40 of every 100,000 people each year, often between ages 30 and 45. An estimated one in 60 people will be affected by the facial paralysis during their lifetime.

Patients typically have trouble moving some parts of their face, which can droop. "It paralyzes the muscles of facial expression affecting the muscles around the eye, so that the eyelids cannot be closed properly, and around the mouth so that smiling, speech and mouth closure are affected," explained study lead author Frank Sullivan, a researcher at the Scottish School of Primary Care in Dundee, Scotland.

The cause is unknown, although there's some suspicion that Bell's palsy may be connected to a viral infection caused by the same strain of herpes that causes cold sores. This infection can recur as shingles long after a chickenpox infection, Sullivan added.

Typically, Bell's palsy clears up on its own over time or after patients are treated with prednisolone, a steroid related to the more commonly known prednisone. Prednisolone stops the immune system from creating so much inflammation.

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 10/17/2007

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Donald Gilden, M.D., chairman, University of Colorado, Denver; Frank Sullivan, Ph.D., researcher, Scottish School of Primary Care, Dundee, U.K.; Oct. 18, 2007, New England Journal of Medicine


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.